S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.02%) $0.926
USD/NOK
(-0.05%) $10.84
USD/GBP
(-0.13%) $0.791
USD/RUB
(-0.09%) $92.49

Realtime updates for Provention Bio Inc [PRVB]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated26 Apr 2023 @ 16:00

0.00% $ 24.98

Live Chart Being Loaded With Signals

Commentary (26 Apr 2023 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases...

Stats
Today's Volume 9.12M
Average Volume 2.84M
Market Cap 2.38B
EPS $0 ( 2024-03-27 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -16.43
ATR14 $0.594 (2.38%)
Insider Trading
Date Person Action Amount type
2023-04-27 Sessa Capital (master), L.p. Sell 15 567 497 Common Stock
2023-04-27 Wysenski Nancy Sell 128 981 Option to Purchase Common Stock
2023-04-27 Wysenski Nancy Sell 22 200 Option to Purchase Common Stock
2023-04-27 Wysenski Nancy Sell 23 000 Option to Purchase Common Stock
2023-04-27 Wysenski Nancy Sell 33 000 Option to Purchase Common Stock
INSIDER POWER
-62.68
Last 100 transactions
Buy: 11 373 023 | Sell: 48 540 195

Volume Correlation

Long: 0.34 (neutral)
Short: 0.37 (neutral)
Signal:(80.187) Neutral

Provention Bio Inc Correlation

10 Most Positive Correlations
KRBP0.886
RICO0.879
NETE0.825
MMAC0.812
LWAC0.809
10 Most Negative Correlations
SQBG-0.875
TCAC-0.873
TCACU-0.869
RMRM-0.85
SVAC-0.82
TLGT-0.819

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Provention Bio Inc Correlation - Currency/Commodity

The country flag -0.88
( strong negative )
The country flag -0.60
( weak negative )
The country flag 0.15
( neutral )
The country flag -0.85
( strong negative )
The country flag -0.52
( weak negative )
The country flag 0.79
( moderate )

Provention Bio Inc Financials

Annual 2022
Revenue: $12.90M
Gross Profit: $12.38M (96.03 %)
EPS: $-1.520
Q4 2022
Revenue: $10.81M
Gross Profit: $10.30M (95.26 %)
EPS: $-0.450
Q3 2022
Revenue: $756 000
Gross Profit: $756 000 (100.00 %)
EPS: $-0.340
Q2 2022
Revenue: $746 000
Gross Profit: $746 000 (100.00 %)
EPS: $-0.460

Financial Reports:

No articles found.

Provention Bio Inc

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators